Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services
FDA, U.S. Food and Drug Administration
U.S. Food & Drug Administration
 
  • A to Z Index
  • Follow FDA
  • FDA Voice Blog
Search
 
Most Popular Searches
 
  • Home
  • Food
  • Drugs
  • Medical Devices
  • Vaccines, Blood & Biologics
  • Animal & Veterinary
  • Cosmetics
  • Radiation-Emitting Products
  • Tobacco Products
 

Import Alert 25-02

  • Print
  • Share
  • E-mail
  • FDA Home
  • Import Program
  • Import Alerts
  • Imports Alerts by Number
  • Import Alert
-

(Note: This import alert represents the Agency's current guidance to FDA field personnel regarding the manufacturer(s) and/or products(s) at issue. It does not create or confer any rights for or on any person, and does not operate to bind FDA or the public).

Import Alert # 25-02
Published Date: 03/18/2011
Type: DWPE
Import Alert Name:
"Detention Without Physical Examination of Morel Mushrooms Due to Adulteration and Substitution"

Reason for Alert:
** In the past, shipments of canned and dried morel mushrooms have been detained due to the presence of Gyromitra esculenta. This mushroom species is known to produce monomethylhydrazine (MMH), a substance which
causes severe gastrointestinal disturbance and, in some cases, death.

In addition to Gyromitra esculenta, CFSAN has identified another species, Verpa bohemica, which can also cause toxic effects in some
individuals. **

Guidance:
** Districts may detain without physical sampling and analysis, any shipments of fresh, dried, or canned morel mushrooms from those manufacturers and/or shippers listed on the Red List below.

Increased surveillance of fresh, dried, and canned morel mushrooms from other firms and countries appears to be warranted.

Product Description:
** All morel and false morel mushrooms (fresh, canned and dried)

Charge:
** Presence of Gyromitrin and similar hydrazine derivatives.

** "The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to ** bear or contain mushroom toxins, a poisonous and deleterious substance which may render it injurious to health [Adulteration, Section 402(a)(1)]."

OASIS charge code - POISONOUS

and

"...it appears to bear or contain species of mushroom other than morels but its labeling fails to reveal the presence of a species of mushroom other than morels ** [Misbranding, Section 403(a)(1)]."

OASIS charge code - FALSE


List of firms and their products subject to Detention without Physical Examination (DWPE) under this Import Alert (a.k.a. Red List)



FRANCE

Plantin SAS
Date Published : 09/16/2009

Route de Nyons/R.C. Carpentras 69 B 21 , Puymeras , St Romain En Viennois, FRANCE
25 P - A 06 Mushroom, Morel, Whole (Button) (Fungi)
Date Published: 09/16/2009

25 P - E 06 Mushroom, Morel, Whole (Button) (Fungi)
Date Published: 09/16/2009

25 P - H 06 Mushroom, Morel, Whole (Button) (Fungi)
Date Published: 09/16/2009


-
-

Links on this page:

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.


  • Accessibility
  • Contact FDA
  • Careers
  • FDA Basics
  • FOIA
  • No Fear Act
  • Site Map
  • Transparency
  • Website Policies
FDA
U.S. Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
Ph. 1-888-INFO-FDA (1-888-463-6332)
Email FDA
  • USA.gov
  • E-mail
  • RSS
  • Twitter
  • Facebook
  • YouTube
  • Flickr
  • For Government
  • For Press
  • Combination Products
  • Advisory Committees
  • Science & Research
  • Regulatory Information
  • Safety
  • Emergency Preparedness
  • International Programs
  • News & Events
  • Training and Continuing Education
  • Inspections/Compliance
  • State & Local Officials
  • Consumers
  • Industry
  • Health Professionals
U.S. Department of Health & Human Services
 

Links on this page: